Frates' participation in the challenge helped raise more than $100 million for efforts to fight the disease, according to the New York Times, in today's bite-sized hospital and health industry news from Massachusetts, Michigan, and Texas.
A record number of U.S. adults say they have put off receiving medical care due to cost, yet many say they are satisfied with their overall costs for health care, according to Gallup's annual Health and Healthcare poll.
Women who use permanent hair dye or chemically straighten their hair may be at a higher risk of developing breast cancer, according to a recent study published in the International Journal of Cancer. However, cancer researchers warned that the findings do not show causation and should be viewed in the appropriate context.
Micromanaging may grant managers peace of mind, but the habit can backfire, eroding trust between them and their direct reports, Serenity Gibbons writes for Harvard Business Review, where she describes three ways managers can kick the habit and develop a better rapport with their reports.
B.J. Miller, a palliative care physician at the University of California, San Francisco's Cancer Center, climbed on top of a commuter train during his sophomore year at Princeton University and was shocked with 11,000 volts of electricity. He survived, and his close brush with death inspired him to become a palliative care physician, Terry Gross writes for NPR's "Shots."
Two federal appeals courts have lifted lower court injunctions blocking a final rule that would allow federal officials to consider whether immigrants are receiving or are likely to receive Medicaid or other public benefits when reviewing their residency applications, but separate injunctions blocking the rule nationwide remain in effect.
The House Ways and Means Committee on Tuesday announced that Congress and the Trump administration have agreed on a renegotiated North American Free Trade Agreement between the United States, Canada, and Mexico that does not include a 10-year exclusivity period for biologic drugs that was backed by pharmaceutical companies.